UPS Shares Slip After Q2 Results
United Parcel Service, Inc. (NYSE:UPS) reported second-quarter FY22 revenue growth of 5.7% year-over-year to $24.8 billion, beating the consensus of…
Reneo Pharmaceuticals Says Metabolic Disorder Program To Enter Next Stage Of Development
Reneo Pharmaceuticals Inc (NASDAQ:RPHM) has reported results from the REN001 long-chain fatty acid oxidation disorders (LC-FAOD) study and provided additional development…
Why Bitcoin- And Ethereum-Related Stock MicroStrategy Is Down Today
MicroStrategy Incorporated (NASDAQ: MSTR) shares are trading lower by 4.48% to $253.95 Tuesday morning after Jefferies downgraded the stock from Hold to Underperform.
Iridium Comm Tops Q2 Backed By Demand For Equipment; Boosts Outlook
Iridium Communications Inc (NASDAQ:IRDM) reported second-quarter FY22 revenue growth of 17% year-on-year to $174.9 million, beating the consensus of $166.5 million.…
Fiserv Shares Gain Following Q2 Revenue Beat; Robust Guidance
Fiserv, Inc (NASDAQ:FISV) reported second-quarter FY22 revenue growth of 10% year-on-year to $4.45 billion, beating the consensus of $4.08 billion. Organic…
Why Vinco Ventures Shares Are Falling Tuesday
Digital media and content company Vinco Ventures (NASDAQ: BBIG) is seeing shares drop Tuesday morning after several press releases were issued Monday.
Shopify Gears Up For 10% Job Cuts, Founder Admits He Overestimated Pandemic Induced E-Commerce Growth: WSJ
Shopify Inc (NYSE:SHOP) braces to slash 1,000 workers, or 10% of its global workforce, marking a retreat from its…
Corning Shares Drop On Missing Q2 Sales Consensus, Mixed Segment Results
Corning Inc (NYSE:GLW) reported second-quarter FY22 core sales growth of 7% year-on-year to $3.76 billion, slightly missing the consensus of $3.78…
Petmed Express Shares Plunge On Q1 Earnings Miss
Petmed Express Inc (NASDAQ:PETS) reported a first-quarter FY22 sales decline of 11.5% year-on-year, to $70.20 million, missing the analyst consensus estimate…
Why Walmart is Trading Higher By More Than 9%: Here Are 25 Stocks Moving Premarket
Gainers
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) rose 64.4% to $1.43 in pre-market trading. Ayala Pharmaceuticals filed request for withdrawal of registration statement on form S-1.